News | April 21, 2008

Cardiac Pacemakers Market to Reach $3.7 Billion by 2010

April 22, 2008 - The cardiac pacemakers market is expected to reach $3.7 billion by 2010, according to the report "Cardiac Pacemakers: A Global Strategic Business Report," published by Global Industry Analysts Inc.

Developing world, China and India with vast population base are primary markets for cardiac rhythm management products. Asia-Pacific is expected to witness the fastest growth both in terms of dollar and unit sales over the 2000-2010 period. Single-chamber pacemakers market in the region is projected to reach $95 million by 2010.

The worldwide cardiac pacemakers market is characterized by relatively mature conditions and intense competition. However, an aging global population, and the subsequent rise in the incidence of cardiovascular diseases, has ensured a steady growth for the pacemakers market. Besides competition from ICD devices, general decline in the prices of pacemakers and loss in consumer confidence amid recent product recalls has led to sluggish growth in the market. In the developing world, China and India with vast population base are primary markets for cardiac rhythm management products.

U.S. and Europe dominate the global cardiac pacemakers market, capturing 75 percent share of the volume sales for 2008, as stated by Global Industry Analysts. However, mature conditions are expected to decelerate the pace of growth in those markets. The relatively untapped markets of Asia-Pacific and Latin America hold enormous growth potential for these devices.

In the U.S., implantable pacemakers represent the leading product segment, capturing a bulk of the pacemakers market, in volume and value terms. Sales from Implantable pacemakers market in the region are projected to reach $1.7 billion by 2010. Mature conditions in the cardiac pacemakers market have significantly eroded prices of the pacing devices, resulting in lower revenue generation and stagnant growth. With ICD and CRT devices expected to drive growth in the overall CRM market, manufacturers are less enthusiastic about developing advanced versions of pacemaker devices. Lack of path-breaking technological innovations and absence of any new indications for pacemakers have further shrunk growth opportunities in the market.

Europe represents the second largest market for cardiac pacemakers. Dual-chamber pacemakers market in the region is estimated at $663 million for 2008.

Major players profiled in the report include Biotronik GmbH, Boston Scientific Corporation, Medtronic, Sorin Group, St. Jude Medical, and Zoll Medical Corporation.

For more information:

Related Content

Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
Ohio State Researchers Prove Human Heart's 'Battery' Has Multiple Backups
News | EP Lab| July 27, 2017
July 27, 2017 — There is good news when it comes to the heart’s sinoatrial node (SAN), the body’s natural...
Medtronic Reactive ATP Therapy Slows Progression of Atrial Fibrillation in Real-World Population
News | Atrial Fibrillation| July 03, 2017
Medtronic recently announced that its Reactive ATP therapy slows the progression of atrial fibrillation (AF) in...
Biosense webster multielectrode balloon RF ablation catheter

The Biosense Webster multi-electrode balloon RF ablation catheter. Each electrode can have varied power settings to avoid damage to underlying tissues like the esophagus. 

Feature | EP Lab| June 22, 2017 | Dave Fornell
Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve...
Pacemakers and Other Cardiac Devices Can Help Solve Forensic Cases
News | Pacemakers| June 20, 2017
Pacemakers and other cardiac devices can help solve forensic cases, according to a study presented at the European...
Sponsored Content | Videos | EP Lab| May 26, 2017
DAIC Editor Dave Fornell takes a tour of some of the most innovative new electrophysiology (EP) technology at the 201
Sponsored Content | Videos | Leads Implantable Devices| May 25, 2017
Bruce Wilkoff, M.D., director of cardiac pacing and tachyarrhythmia devices at Cleveland Clinic, discusses advancemen
Sponsored Content | Videos | Pacemakers| May 23, 2017
Vivek Reddy, M.D., director of cardiac arrhythmia services and professor of medicine, cardiology, Mount Sinai Hospita
micra leadless pacemaker
Feature | Pacemakers| May 16, 2017
May 16, 2017 - The preliminary results for the Medtronic Micra Transcatheter Pacing System (TPS) Post-Approval Regist
Sponsored Content | Videos | Pacemakers| May 16, 2017
This video, provided by Medtronic, demonstrates the implantation of Micra transcatheter pacing system (TPS).
Overlay Init